Finally, it was found that miR‐150‐5p‐EVs reduced the levels of ALT, AST and TB versus CCl4 + oe‐NC, relative to CCl4 + miR‐150‐5p‐EVs + oe‐NC, but this trend was also reversed by oe‐CXCL1 treatment (Figure 8G). This evidence concerns the gene CXCL1 and tuberculosis.